Myeloma

Myeloma

More than 550 clinical trials are currently accepting participants diagnosed with Myeloma.

Myeloma, also frequently referred to as multiple myeloma, is a type of cancer that originates from plasma cells in the bone marrow. The terms 'multiple myeloma' and 'myeloma' are used interchangeably. In myeloma, the bone marrow, which is the spongy tissue inside certain large bones, produces an excessive number of abnormal (cancerous) plasma cells. Plasma cells are a type of white blood cell that plays a vital role in the immune system by producing antibodies to combat infections. When these cells become cancerous, they can affect multiple parts of the body and its ability to produce normal blood cells and antibodies effectively, resulting in an increased risk of infections, bone pain, and fractures, as well as problems related to abnormal blood cell counts.

What clinical trials are

Learn more

Before you take part in a clinical trial

Learn more

Find the right clinical trial

Learn more